Delivery Order SPE2DR25D9131-SPE2DR26FCPC2
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract is firm fixed-price with no set-aside designation, reflecting DMS Pharmaceutical Group's competitive capability in unrestricted federal procurement. The delivery order has an ultimate completion date of November 24, 2025, and represents one of...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The delivery order, issued on October 28, 2025, with an ultimate completion date of November 19, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. This award was issued...
- The Defense Logistics Agency awarded a $16,249.95 firm fixed-price delivery order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for STELARA 90 mg/ml syringes. This delivery order, issued on October 30, 2025, represents a single transaction under DMS Pharmaceutical Group's broader Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $82,920.65 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90mg/mL syringes. This firm fixed-price delivery order, issued on October 24, 2025, represents one of numerous pharmaceutical supply orders placed with DMS Pharmaceutical Group under the DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V)...
- The Defense Logistics Agency issued a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler headquartered in Park Ridge, Illinois, for the supply of Stelara 90 mg/mL syringes. The contract was awarded on October 21, 2025, with an ultimate completion date of November 12, 2025, under a firm fixed-price arrangement with no set-aside designation. This delivery order was issued pursuant to DMS Pharmaceutical Group's Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $116,088.91 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on November 4, 2025, with an ultimate completion date of November 26, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement....
- DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, was awarded a delivery order on November 4, 2025, by the Defense Logistics Agency for STELARA 90 MG/ML syringes valued at $49,752.39 under a firm fixed-price contract structure. This delivery order was issued without a set-aside designation, demonstrating the company's competitive capability in unrestricted federal procurement. The award is associated with DMS Pharmaceutical...
- The Defense Logistics Agency has issued a delivery order valued at approximately $49,752 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, awarded on October 29, 2025, with an ultimate completion date of November 20, 2025, contains no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal...
- The Defense Logistics Agency awarded a delivery order valued at $16,249.95 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on October 27, 2025, with an ultimate completion date of November 18, 2025, carries no set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The award is...
- The Defense Logistics Agency awarded a delivery order valued at $33,168.26 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Stelara 90 mg/ml syringes. This firm fixed-price delivery order, issued on November 3, 2025, with an ultimate completion date of November 25, 2025, was awarded without a set-aside designation, demonstrating the contractor's competitive capability in unrestricted federal procurement. The...
- SPE2DR25D9131Indefinite Delivery Contract
- SPE2DR25D9131-SPE2DR26FCPC2Delivery Order
The Defense Logistics Agency awarded a firm fixed-price delivery order valued at $16,584.13 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of STELARA 90 mg/ml syringes. The contract was awarded on November 7, 2025, with an ultimate completion date of December 2, 2025, and carries no set-aside designation, indicating the award was made through full and open competition. This delivery order is issued under DMS Pharmaceutical Group's single-award Indefinite Delivery Contract with the Defense Logistics Agency's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a comprehensive $30.3 billion acquisition strategy designed to support recurring pharmaceutical supply needs across Department of Defense military healthcare facilities worldwide. As a critical regional prime vendor contractor under PPV-G GEN V, DMS Pharmaceutical Group is authorized to supply a comprehensive range of pharmaceutical products including branded and generic prescription medications, biologics, vaccines, and medical consumables to support DOD healthcare operations. The company's IDC, valued at $499,999,999 and extending through December 31, 2036, positions it to serve as a key pharmaceutical supplier for military medical systems globally. DMS Pharmaceutical Group's selection reflects its demonstrated capability to deliver specialized pharmaceutical products efficiently to federal military healthcare facilities, with the STELARA delivery order representing one of numerous individual issuances under this broader prime vendor contract framework.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $16.6k | 11/7/25 |